IP Library Granted Patent US 8,066,689
Granted Patent B2
US 8,066,689 · App. 11/776,097 · Granted Nov 29, 2011

Methods and systems for submucosal implantation of a device for diagnosis and treatment with a therapeutic agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,066,689
App. No.
11/776,097
Granted
Nov 29, 2011
Kind
B2
Abstract

Instruments, systems, implants, and methods are provided for performing submucosal medical procedures in a desired area of the digestive tract using endoscopy. Instruments include a safe access needle injection instrument, a submucosal tunneling instrument, a submucosal dissection instrument, and a mucosal resection device. A submucosal implant device for diagnosing and treating disorders of the body may be implanted. A passive submucosal implant device may take the form of a drug delivery depot in which a therapeutic agent within the depot elutes from the depot according to a predetermined elution profile. An active submucosal implant device may take the form of a drug delivery device that incorporates a self-contained diagnostic system to determine the appropriate delivery time and dosage of a therapeutic agent to be administered.

Claims (53)

1. A method of placing an implantable device within a submucosal layer, comprising:

elevating a mucosal layer by injecting a fluid into the submucosal layer using a needle assembly;

inserting a submucosal tunneling instrument into the elevated mucosal layer said submucosal tunneling instrument comprising an elongate tubular member having proximal and distal ends and a lumen extending therethrough and an expandable member having proximal and distal ends wherein the proximal end of said expandable member is attached to the distal end of said tubular member and the distal end of said expandable member is everted and positioned within the lumen of said tubular member;

operating said submucosal tunneling instrument to expand distally to create an elongate tunnel in the submucosal layer;

removing the submucosal tunneling instrument from said elongate tunnel;

positioning a submucosal dissecting instrument within the elongate tunnel formed by said tunneling instrument, said submucosal dissecting instrument discrete from said tunneling instrument such that said submucosal dissecting instrument is separately insertable from said submucosal tunneling instrument into said elongate tunnel;

operating said submucosal dissecting instrument to expand radially, within the elongate tunnel to thereby dissect a large area having a diameter larger than the diameter of said elongate tunnel; and

depositing a drug delivery device within the large area created by the submucosal dissecting instrument.

2. A method according to claim 1 wherein said implant device is an active drug delivery device.

3. A method according to claim 2 , wherein said expandable member of said submucosal tunneling instrument comprises a balloon.

4. A method according to claim 3 , further comprising delivering therapeutic agents from said drug delivery device to the submucosal layer.

5. A method according to claim 3 , further comprising controlling said drug delivery device externally by telemetry to deliver therapeutic agents.

6. A method of placing an implantable device within a submucosal layer, comprising:

providing a least one submucosal instrument;

elevating a mucosal layer by delivering a fluid into the submucosal layer;

inserting one of said submucosal instruments into the elevated mucosal layer;

operating one of said submucosal instruments to first expand distally to form an elongate tunnel in the submucosal layer;

then operating another one of said submucosal instruments in said formed elongate tunnel to second expand substantially radially and not substantially distally and dissect the mucosal layer from the submucosal layer to define a dissected space; and

depositing a drug delivery device within said dissected space.

7. A method according to claim 6 , wherein said at least one submucosal instrument comprises a needle knife.

8. A method according to claim 6 wherein said at least one submucosal instrument includes a submucosal tunneling instrument adapted to distally expand through tissue and a distinct submucosal dissection instrument adapted to radially expand within tissue.

9. A method according to claim 8 wherein said submucosal tunneling instrument comprises an elongate tubular member having proximal and distal ends and a lumen extending therethrough and an expandable member having proximal and distal ends wherein the proximal end of said expandable member is attached to the distal end of said tubular member and the distal end of said expandable member is everted and positioned within the lumen of said tubular member.

10. A method according to claim 9 wherein said implant device is an active drug delivery device.

11. A method according to claim 10 , wherein said expandable member of said submucosal tunneling instrument comprises a balloon.

12. A method according to claim 11 wherein said step of depositing said drug delivery device further includes depositing a plurality of drug delivery devices.

13. A method of placing an implantable device within a submucosal layer, comprising:

elevating a mucosal layer by delivering a fluid into the submucosal layer;

inserting a submucosal tunneling instrument into the elevated mucosal layer, said tunneling instrument including a distal end having an everted member that is axially and radially expandable;

operating said submucosal tunneling instrument to create an elongate tunnel in the submucosal layer by axially and radially expanding said distal end of said tunneling instrument;

then removing said submucosal tunneling instrument from said elongate tunnel;

then inserting a submucosal dissecting instrument distinct from said submucosal tunneling instrument into said elongate tunnel;

then dissecting an area under the mucosal layer with the submucosal dissecting instrument, the area having a diameter larger than a diameter of said elongate tunnel; and

depositing a drug delivery device within the dissected area.

14. A method according to claim 13 , further comprising delivering therapeutic agents from said drug delivery device to the submucosal layer.

15. A method according to claim 13 , further comprising controlling said drug delivery device externally by telemetry to deliver therapeutic agents.

16. A method according to claim 13 , wherein the everted member is a balloon.

17. A method of placing an implantable device within a submucosal layer, comprising:

elevating a mucosal layer by delivering a fluid into the submucosal layer;

inserting a submucosal tunneling instrument into the elevated mucosal layer, said tunneling instrument adapted to distally expand through tissue, said tunneling instrument comprising an elongate tubular member having proximal and distal ends and a lumen extending therethrough and an expandable member having proximal and distal ends wherein the proximal end of said expandable member is attached to the distal end of said tubular member and the distal end of said expandable member is everted and positioned within the lumen of said tubular member;

operating said tunneling instrument to first expand distally to form an elongate tunnel in the submucosal layer;

then inserting a submucosal dissecting into said elongate tunnel, said dissecting instrument adapted to radially expand within tissue;

then operating said dissecting instrument in said formed elongate tunnel to second expand radially and dissect the mucosal layer from the submucosal layer to define a dissected space; and

depositing a drug delivery device within said dissected space.

18. A method of placing an implantable device within a submucosal layer, comprising:

elevating a mucosal layer by injecting a fluid into the submucosal layer using a needle assembly;

inserting a submucosal tunneling instrument into the elevated mucosal layer;

operating said submucosal tunneling instrument to expand distally to create an elongate tunnel in the submucosal layer;

removing the submucosal tunneling instrument from said elongate tunnel;

positioning a submucosal dissecting instrument within the elongate tunnel formed by said tunneling instrument, said submucosal dissecting instrument discrete from said tunneling instrument such that said submucosal dissecting instrument is separately insertable from said submucosal tunneling instrument into said elongate tunnel;

operating said submucosal dissecting instrument to expand substantially radially but not substantially distally within the elongate tunnel to thereby dissect a large area having a diameter larger than the diameter of said elongate tunnel; and

depositing a drug delivery device within the large area created by the submucosal dissecting instrument.

19. A method according to claim 18 , wherein said tunneling instrument includes an elongate tubular member having proximal and distal ends and a lumen extending therethrough and an axially and radially expandable member, and wherein the distal end of said elongate tubular member is adapted to enter an opening through the mucosal layer and into the submucosal layer.

20. A method according to claim 19 , wherein said expandable member has proximal and distal ends and said proximal end of said expandable member is attached to the distal end of said tubular member and the distal end of said expandable member is everted and positioned within the lumen of said tubular member, wherein said distal end of said elongate tubular member is adapted to enter an opening through the mucosal layer and into the submucosal layer.

Assignments (17)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2023
From: APOLLO ENDOSURGERY, INC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 066142/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2023
From: APOLLO ENDOSURGERY US, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 066142/0705 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →
RELEASE OF SECURITY INTEREST Recorded Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
SECURITY INTEREST Recorded Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2019
From: APOLLO ENDOSURGERY US, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0687 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0328 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0343 →
CHANGE OF NAME Recorded Mar 27, 2017
From: APOLLO ENDOSURGERY, INC.
To: APOLLO ENDOSURGERY US, INC.
Reel/Frame 042106/0912 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 30, 2016
From: APOLLO ENDOSURGERY US, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0821 →
TERMINATION OF PATENT SECURITY INTEREST (RECORDED ON 12/3/13 AT REEL/FRAME 031756/0729 AND ON 1/2/14 AT REEL/FRAME 031910/0460) Recorded Mar 2, 2015
From: OXFORD FINANCE LLC, AS AGENT
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 035120/0740 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 2, 2015
From: APOLLO ENDOSURGERY, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 035120/0843 →
SECURITY AGREEMENT Recorded Dec 3, 2013
From: APOLLO ENDOSURGERY, INC.
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 031756/0729 →
RELEASE OF SECURITY INTEREST Recorded Dec 2, 2013
From: COMERICA BANK
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 031699/0959 →
SECURITY AGREEMENT Recorded Jun 30, 2011
From: APOLLO ENDOSURGERY, INC.
To: COMERICA BANK, A TEXAS BANKING ASSOCIATION
Reel/Frame 026530/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2007
From: MITELBERG, VLADIMIR; JONES, DONALD K.; YUAN, DAVID Y.; NAGLREITER, BRETT E.; MCWILLIAMS, DENNIS L.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 020312/0258 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2007
From: PASRICHA, PANKAJ J.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE
Reel/Frame 020313/0068 →